Related Experiment Video
Updated: May 26, 2026
07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma
J Haniball1, V P Sumathi, L-G Kindblom
1The Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic Hospital NHS Foundation Trust, Bristol Road South, Birmingham B31 2AP, UK.
Sarcoma
|December 23, 2011
Summary
The round cell component in myxoid/round-cell liposarcoma (MRCLS) is a key adverse prognostic factor. Higher proportions of this component increase risks for recurrence, metastasis, and death, suggesting intensified treatment strategies.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Prognostics
Background:
- Myxoid/round-cell liposarcoma (MRCLS) is a subtype of soft tissue sarcoma.
- Prognostic factors and metastatic patterns in MRCLS require further elucidation.
- The significance of the round cell component in MRCLS prognosis is not fully understood.
Purpose of the Study:
- To investigate prognostic factors in MRCLS patients.
- To determine the impact of the round cell component on patient outcomes.
- To identify common metastatic patterns and inform follow-up strategies.
Main Methods:
- Retrospective analysis of clinical, morphologic, and follow-up data from 160 MRCLS patients.
- Statistical analysis to evaluate prognostic significance of the round cell component.
- Review of treatment modalities including surgical excision and adjuvant radiotherapy.
Main Results:
- A round cell component was present in varying proportions across evaluated tumors.
- Local recurrence (12%) was linked to marginal/intralesional margins and the round cell component.
- Disease-specific survival decreased with higher proportions of the round cell component (75% at 5 years, 56% at 10 years).
- Extrapulmonary metastases were observed in 73% of metastatic cases.
Conclusions:
- The presence of any round cell component is a significant adverse prognostic factor in MRCLS.
- Patients with >5% round cell component face higher risks of recurrence, metastasis, and mortality.
- Adjuvant radiotherapy and potentially chemotherapy should be considered for high-risk patients.
- Optimal monitoring for extrapulmonary metastases requires further investigation.
